Uterine mesenchymal tumor (UMT) encompasses a heterogeneous group of lesions ranging from benign variants, primarily leiomyomas, to malignant sarcomas [1]. Misdiagnosing sarcoma, particularly leiomyosarcoma which are the most common histological type, can have lethal consequences due to their poor prognosis [2,3]. Additionally, the large size of these malignant tumors, which may be underdiagnosed as myomas and subsequently referred for morcellation during minimally invasive surgery, can lead to …